Cheryl Scott's most recent trade in Progyny Inc was a trade of 14,667 Common Stock done at an average price of $13 . Disclosure was reported to the exchange on June 1, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Progyny Inc | Cheryl Scott | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 13.00 per share. | 01 Jun 2026 | 14,667 | 34,439 (0%) | 0% | 13 | 190,671 | Common Stock |
| Progyny Inc | Cheryl Scott | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2026 | 14,667 | 29,333 | - | - | Stock Option (Right to Buy) | |
| Progyny Inc | Cheryl Scott | Director | Sale of securities on an exchange or to another person at price $ 26.38 per share. | 01 Jun 2026 | 7,439 | 19,772 (0%) | 0% | 26.4 | 196,278 | Common Stock |
| Progyny Inc | Cheryl Scott | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 26.38 per share. | 01 Jun 2026 | 7,228 | 27,211 (0%) | 0% | 26.4 | 190,675 | Common Stock |
| Progyny Inc | Cheryl Scott | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2026 | 27,119 | 27,119 | - | - | Stock Option (Right to Buy) | |
| Progyny Inc | Cheryl Scott | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2026 | 5,660 | 19,772 (0%) | 0% | 0 | Common Stock | |
| Progyny Inc | Cheryl Scott | Director | Sale of securities on an exchange or to another person at price $ 22.07 per share. | 11 Jun 2025 | 2,675 | 14,112 (0%) | 0% | 22.1 | 59,037 | Common Stock |
| Evolent Health Inc (Class A) | Cheryl Scott | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2025 | 21,979 | 73,476 (0%) | 0% | 0 | Class A Common Stock | |
| Progyny Inc | Cheryl Scott | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 May 2025 | 30,401 | 30,401 | - | - | Stock Option (Right to Buy) | |
| Progyny Inc | Cheryl Scott | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 May 2025 | 6,689 | 16,787 (0%) | 0% | 0 | Common Stock | |
| Progyny Inc | Cheryl Scott | Director | Sale of securities on an exchange or to another person at price $ 28.39 per share. | 28 Jun 2024 | 1,462 | 10,098 (0%) | 0% | 28.4 | 41,506 | Common Stock |
| Evolent Health Inc (Class A) | Cheryl Scott | Director | 06 Jun 2024 | 7,709 | 51,497 (0%) | 0% | 0 | Class A Common Stock | ||
| Progyny Inc | Cheryl Scott | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2024 | 23,212 | 23,212 | - | - | Stock Option (Right to Buy) | |
| Progyny Inc | Cheryl Scott | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2024 | 5,147 | 11,560 (0%) | 0% | 0 | Common Stock | |
| Progyny Inc | Cheryl Scott | Director | Sale of securities on an exchange or to another person at price $ 37.27 per share. | 27 Jun 2023 | 1,170 | 9,744 (0%) | 0% | 37.3 | 43,606 | Common Stock |
| Evolent Health Inc (Class A) | Cheryl Scott | Director | 14 Jun 2023 | 2,365 | 53,788 (0%) | 0% | 30.0 | 70,974 | Class A Common Stock | |
| Evolent Health Inc (Class A) | Cheryl Scott | Director | 08 Jun 2023 | 5,049 | 56,153 (0%) | 0% | 0 | Class A Common Stock | ||
| Progyny Inc | Cheryl Scott | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 May 2023 | 16,990 | 16,990 | - | - | Stock Option (Right to Buy) | |
| Progyny Inc | Cheryl Scott | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 May 2023 | 3,654 | 10,914 (0%) | 0% | 0 | Common Stock | |
| Progyny Inc | Cheryl Scott | Director | Sale of securities on an exchange or to another person at price $ 40.78 per share. | 07 Nov 2022 | 850 | 7,260 (0%) | 0% | 40.8 | 34,663 | Common Stock |
| Progyny Inc | Cheryl Scott | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Oct 2022 | 14,500 | 14,500 | - | - | Stock Option (Right to Buy) | |
| Progyny Inc | Cheryl Scott | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Oct 2022 | 2,900 | 8,110 (0%) | 0% | 0 | Common Stock | |
| Evolent Health Inc (Class A) | Cheryl Scott | Director | 31 Aug 2022 | 3,100 | 51,104 (0%) | 0% | 36.8 | 113,956 | Class A Common Stock | |
| Evolent Health Inc (Class A) | Cheryl Scott | Director | 09 Jun 2022 | 5,564 | 54,204 (0%) | 0% | 0 | Class A Common Stock | ||
| Evolent Health Inc (Class A) | Cheryl Scott | Director | 31 Dec 2021 | 10,000 | 38,640 (0%) | 0% | 0 | Class A Common Stock | ||
| Progyny Inc | Cheryl Scott | Director | Sale of securities on an exchange or to another person at price $ 66.30 per share. | 08 Nov 2021 | 2,000 | 5,210 (0%) | 0% | 66.3 | 132,600 | Common Stock |
| Progyny Inc | Cheryl Scott | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Oct 2021 | 14,658 | 14,658 | - | - | Stock Option (right to buy) | |
| Progyny Inc | Cheryl Scott | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Oct 2021 | 2,210 | 7,210 (0%) | 0% | 0 | Common Stock |